{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:02:32Z","timestamp":1775840552580,"version":"3.50.1"},"reference-count":23,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Laryngorhinootologie"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1055\/a-1309-6631","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T03:11:40Z","timestamp":1612235500000},"page":"134-145","source":"Crossref","is-referenced-by-count":1,"title":["Biologika: Neue Therapieoption bei schwerer chronisch polyp\u00f6ser Rhinosinusitis"],"prefix":"10.1055","volume":"100","author":[{"given":"Mandy","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Zahnert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,2,1]]},"reference":[{"issue":"01","key":"ref1","first-page":"38","article-title":"Guideline for \u201crhinosinusitis\u201d-long version: S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery","volume":"66","author":"B A Stuck","year":"2018","journal-title":"HNO"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4193\/Rhin20.601","article-title":"Executive summary of EPOS 2020 including integrated care pathways","volume":"58","author":"W J Fokkens","year":"2020","journal-title":"Rhinology"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino50E2","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"W J Fokkens","year":"2012","journal-title":"Rhinology"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4193\/Rhin18.061","article-title":"Epidemiology of chronic rhinosinusitis in Bushehr, southwestern region of Iran: a GA2LEN study","volume":"57","author":"A Ostovar","year":"2019","journal-title":"Rhinology"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/all.13042","article-title":"Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample","volume":"72","author":"A G Hirsch","year":"2017","journal-title":"Allergy"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.alit.2014.12.006","article-title":"Immunopathology of chronic rhinosinusitis","volume":"64","author":"A Kato","year":"2015","journal-title":"Allergol Int"},{"issue":"129","key":"ref7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1183\/09059180.00004013","article-title":"Anti-interleukin-5 therapy in severe asthma","volume":"22","author":"G Garcia","year":"2013","journal-title":"Eur Respir Rev"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"J M Mjosberg","year":"2011","journal-title":"Nat Immunol"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/cea.12462","article-title":"Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia","volume":"45","author":"J Ho","year":"2015","journal-title":"Clin Exp Allergy"},{"issue":"05","key":"ref10","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"P Tomassen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"ref11","first-page":"CD011996","article-title":"Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis","volume":"4","author":"L Y Chong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"08","key":"ref12","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/lary.24477","article-title":"Is montelukast indicated for treatment of chronic rhinosinusitis with polyposis?","volume":"124","author":"T L Smith","year":"2014","journal-title":"Laryngoscope"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s00108-010-2661-y","article-title":"Analgetikaintoleranz","volume":"51","author":"C Umbreit","year":"2010","journal-title":"Internist"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.18176\/jiaci.0433","article-title":"Safety and Efficacy of Aspirin Desensitization Combined With Long-Term Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease","volume":"30","author":"R Li","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/000348941112000304","article-title":"Revision rates after endoscopic sinus surgery: a recurrence analysis","volume":"120","author":"D Mendelsohn","year":"2011","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial","volume":"140","author":"C Bachert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"05","key":"ref23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial","volume":"315","author":"C Bachert","year":"2016","journal-title":"JAMA"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"C Bachert","year":"2019","journal-title":"Lancet"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"P Gevaert","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"03","key":"ref27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"P Gevaert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"03","key":"ref28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaci.2014.02.007","article-title":"Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab","volume":"134","author":"A Long","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/all.13875","article-title":"EUFOREA consensus on biologics for CRSwNP with or without asthma","volume":"74","author":"W J Fokkens","year":"2019","journal-title":"Allergy"},{"issue":"08","key":"ref30","doi-asserted-by":"publisher","DOI":"10.1055\/a-1197-0136","article-title":"Positionspapier: Anwendung von Biologika bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem \u2013 Empfehlungen des \u00c4rzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und\u00a0Umweltmedizin und Rhinologie und Rhinochirurgie der\u00a0Deutschen Gesellschaft f\u00fcr HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)","volume":"99","author":"L Klimek","year":"2020","journal-title":"Laryngo-Rhino-Otologie"}],"container-title":["Laryngo-Rhino-Otologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1309-6631.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T03:12:30Z","timestamp":1612235550000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1309-6631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":23,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2021,2,1]]},"published-print":{"date-parts":[[2021,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1309-6631","relation":{},"ISSN":["0935-8943","1438-8685"],"issn-type":[{"value":"0935-8943","type":"print"},{"value":"1438-8685","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}